IndraLab

Statements


USP37 inhibits Chemical Sensitivity Human Breast Cancer Cells. 1 / 1
| 1

eidos
"USP37 downregulation elevates the Chemical Sensitivity of Human Breast Cancer Cells to Adriamycin Background : The evolution of adriamycin ( ADR ) resistance in the treatment of breast cancer often leads to a poor prognosis in patients ."